Patient perspectives of telemedicine in gynecologic oncology during COVID

•Contrary to past studies, gynecologic oncology patients are hesitant to telemedicine.•The pandemic did not increase patient’s comfort with telemedicine.•Patients are more agreeable to telemedicine under specific circumstances. Healthcare rapidly expanded the use of telemedicine during the COVID- 19 pandemic. Research regarding telemedicine benefits and patient perspectives during COVID are limited. The aim of this study was to determine how the pandemic impacted patient perspectives and value of telemedicine in gynecologic oncology. Across-sectionalsurveywas distributed to patientspresenting for an appointment to thegynecologic oncology ambulatoryclinic.The surveyassessedpatient demographics, frequency of technology use, and preferences of telemedicine use in their care. Descriptive statistics were generated and Pearson’s chi square and analysis of variance (ANOVA) were used for statistical analysis. 116 patientscompleted the survey.Respondentage range was 20–70 years old. Most respondents (80 %) had a cancer diagnosis. Nearly all (91 %)patients had access to online medical records via an online portal. Increased use of technology was not associated with agreeing to a telemedicine visit. Only 36 % stated they would feel comfortable with a telemedicine visit with a gynecologic oncologist. Patients were more willing to agree to video rather than telephone visits (41.8 % vs 24.5 %). The pandemic did not affect patient comfort level with telemedicine. Despite increased use and overall favorable impression, patients were not more eager to participate in telemedicine during the pandemic. Patients are open to incorporating telemedicine more often in follow up settings.